After, synthesis and characterization, we tested the new series of β-carbolines for anticancer activity to obtain a structure-activity relationship regarding their antiproliferative activity with the expectation that since p53 and its target genes which are important in apoptosis pathways in cancer cells, our compounds will exhibit anticancer effects. This evidence concerns the gene TP53 and cancer.